We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Advice on Patient-Reported Outcome Instruments
FDA Issues Advice on Patient-Reported Outcome Instruments
The FDA spelled out best practices for the use of patient-reported outcome (PRO) instruments in the development, evaluation, and surveillance of medical devices, in a newly released draft guidance.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor